Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe condition label 'Melanoma' and the related topics section including 'MedlinePlus Genetics' have been removed from the study details, reducing explicit disease context and access to patient-oriented resources.SummaryDifference0.2%

- Check11 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' signaling the study is not enrolling. The page adds new help sections and standardizes the Intervention/Treatment label, with a site revision to v3.6.0.SummaryDifference0.6%

- Check18 days agoChange DetectedFooter shows Revision: v3.5.5, replacing v3.5.4. This indicates a minor platform/template update without changes to the study content.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page now shows related topics for Melanoma and MedlinePlus Genetics, linking the study to the disease context and a genetics information resource.SummaryDifference0.2%

- Check33 days agoChange DetectedThe Melanoma condition label appears to be removed from the study page, along with the related topics header and the MedlinePlus Genetics reference. This reduces disease-specific context and access to related resources for readers.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page revision string was updated from v3.5.3 to v3.5.4, indicating a new, minor version of the page. This appears to be an administrative update rather than a change to study content or functionality.SummaryDifference0.1%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.